Please take a moment to complete the conference evaluation survey.
ISMB 2014 Online Proceedings available at: http://bioinformatics.oxfordjournals.org/content/30/12.toc
Have a look at the conference photo's
See you next year in Dublin,
Congratulations to all the ISMB 2014 Award Winners
The Intelligent Systems for Molecular Biology (ISMB) conference brings together computational biology researchers of every career stage from around the world. Hosted by the International Society for Computational Biology (ISCB), ISMB has grown over 22 years to become the world's largest bioinformatics/computational biology conference.
ISMB attracts top international scientists in the life sciences and offers a strong scientific program and the broadest scope of any international bioinformatics/computational biology. Topics of interest include sequence analysis, evolution and phylogeny, comparative genomics, protein structure, molecular and supramolecular dynamics, molecular evolution, gene regulation and transcriptomics, RNA biology, proteomics, systems biology, ontologies, databases and data integration, text mining and information extraction, and human health.
In addition, join us prior to ISMB on July 11 & 12 to participate in the Special Interest Group Meetings, Satellite Meetings,Student Council Symposium and Tutorials.
Attend ISMB July 13-15, 2014 to present your research, learn about the latest developments in the field, network with colleagues, and help shape the future of computational biology and bioinformatics!
2014 ISCB Fellows Keynote
Russ B. Altman, MD, PhD
Professor of Bioengineering, Genetics, and Medicine and Computer Science
Director, Biomedical Informatics Training Program
Stanford University, United States
Presentation Title: Informatics for understanding drug response at all scales
Presentation Time: Tuesday July 15, 4:40 - 5:40
Russ Biagio Altman is a professor of bioengineering, genetics, & medicine (and of computer science, by courtesy) and past chairman of the Bioengineering Department at Stanford University. His primary research interests are in the application of computing and informatics technologies to basic biological problems relevant to medicine. He is particularly interested in methods for understanding drug action at molecular, cellular, organism and population levels. His lab studies how human genetic variation impacts drug response (e.g. http://www.pharmgkb.org/). Other work focuses on the analysis of biological molecules to understand the action, interaction and adverse events of drugs (http://features.stanford.edu/). He leads one of seven NIH-supported National Centers for Biomedical Computation, focusing on physics-based simulation of biological structures (http://simbios.stanford.edu/). Dr. Altman holds an A.B. from Harvard College, and M.D. from Stanford Medical School, and a Ph.D. in Medical Information Sciences from Stanford. He received the U.S. Presidential Early Career Award for Scientists and Engineers and a National Science Foundation CAREER Award. He is a fellow of the American College of Physicians, the American College of Medical Informatics, and the American Institute of Medical and Biological Engineering. He is a member of the Institute of Medicine of the National Academies. He is a past-president, founding board member, and a Fellow of the International Society for Computational Biology, and the President-Elect of the American Society for Clinical Pharmacology & Therapeutics. He currently chairs the Science Board advising the FDA Commissioner. He is an organizer of the annual Pacific Symposium on Biocomputing (http://psb.stanford.edu/), and a founder of Personalis, Inc. He won the Stanford Medical School graduate teaching award in 2000.